2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | 10.566 | 44.665 | 64.499 | 60.729 | 59.626 | 91.869 | 105.575 | 113.635 |
Total Income - EUR | - | - | 10.566 | 45.025 | 64.499 | 60.729 | 60.624 | 91.921 | 105.653 | 113.635 |
Total Expenses - EUR | - | - | 5.224 | 20.011 | 19.857 | 19.846 | 26.684 | 62.445 | 49.195 | 49.731 |
Gross Profit/Loss - EUR | - | - | 5.342 | 25.014 | 44.642 | 40.883 | 33.940 | 29.476 | 56.459 | 63.905 |
Net Profit/Loss - EUR | - | - | 5.236 | 24.567 | 43.997 | 40.276 | 33.549 | 28.727 | 55.423 | 62.791 |
Employees | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Ambrinomed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | 0 | 3.277 | 8.315 | 7.987 | 7.747 | 69.973 | 61.224 | 52.100 |
Current Assets | - | - | 6.586 | 23.738 | 37.616 | 35.140 | 65.437 | 50.002 | 40.180 | 18.669 |
Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | - | - | 0 | 0 | 32 | 202 | 0 | 0 | 38.528 | 0 |
Cash | - | - | 6.586 | 23.738 | 37.584 | 24.401 | 54.982 | 39.727 | 1.652 | 2.496 |
Shareholders Funds | - | - | 5.281 | 24.620 | 44.048 | 41.325 | 46.889 | 50.318 | 58.938 | 63.363 |
Social Capital | - | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | 1.305 | 2.395 | 1.883 | 1.802 | 26.296 | 69.657 | 42.466 | 7.406 |
Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ambrinomed Srl